Drug interaction classified as: synergy
Source: DDInter
Beta-lactamase inhibitor · Enzyme inhibitor
Clavulanic acid has a β-lactam ring but no antibacterial activity of its own. It inhibits a wide variety of β-lactamases (class II to class V, but not class I cephalosporinase) produced by both gram-positive and gram-negative bacteria. It is a 'progressive' or 'suicide' inhibitor, binding reversibly initially and then covalently to β-lactamase, leading to its inactivation. It permeates the outer layers of the cell wall of gram-negative bacteria and inhibits the periplasmically located β-lactamase.
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Effective against β-lactamase producing H. influenzae, N. gonorrhoeae and other organisms.
Source: KDT 7e · p698
6 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team